1. Home
  2. CCRD vs GNFT Comparison

CCRD vs GNFT Comparison

Compare CCRD & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRD
  • GNFT
  • Stock Information
  • Founded
  • CCRD 1973
  • GNFT 1999
  • Country
  • CCRD United States
  • GNFT France
  • Employees
  • CCRD N/A
  • GNFT N/A
  • Industry
  • CCRD
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CCRD
  • GNFT Health Care
  • Exchange
  • CCRD Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • CCRD 192.4M
  • GNFT 172.2M
  • IPO Year
  • CCRD N/A
  • GNFT 2019
  • Fundamental
  • Price
  • CCRD $22.39
  • GNFT $3.60
  • Analyst Decision
  • CCRD Hold
  • GNFT Strong Buy
  • Analyst Count
  • CCRD 1
  • GNFT 1
  • Target Price
  • CCRD $15.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • CCRD 50.8K
  • GNFT 3.9K
  • Earning Date
  • CCRD 02-12-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • CCRD N/A
  • GNFT N/A
  • EPS Growth
  • CCRD 6.70
  • GNFT N/A
  • EPS
  • CCRD 0.49
  • GNFT 0.47
  • Revenue
  • CCRD $54,733,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • CCRD $1.95
  • GNFT $145.20
  • Revenue Next Year
  • CCRD $12.19
  • GNFT N/A
  • P/E Ratio
  • CCRD $46.32
  • GNFT $7.58
  • Revenue Growth
  • CCRD N/A
  • GNFT 175.45
  • 52 Week Low
  • CCRD $10.02
  • GNFT $3.35
  • 52 Week High
  • CCRD $24.97
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • CCRD 50.86
  • GNFT 42.09
  • Support Level
  • CCRD $22.11
  • GNFT $3.35
  • Resistance Level
  • CCRD $23.88
  • GNFT $3.66
  • Average True Range (ATR)
  • CCRD 1.10
  • GNFT 0.10
  • MACD
  • CCRD -0.18
  • GNFT 0.03
  • Stochastic Oscillator
  • CCRD 23.21
  • GNFT 45.45

About CCRD CoreCard Corporation

CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: